ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1955

Is the Pattern of Capillary Deposition of Complement Membrane Attack COPMLEX  Useful in the Differential Diagnosis of Inflammatory?

Patrick Gordon1, Nuria Villagra2, Istvan Bodi2, Andrew King2, Stefan Buk2, Tibor Hortobagyi2 and Safa Al-Sarraj2, 1Department of Rheumatology, King's College London, London, United Kingdom, 2Department of Clinical Neuropathology, King's College Hospital, London, United Kingdom

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Connective tissue diseases, dermatomyositis, diagnosis and myositis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Muscle Biology, Myositis and Myopathies: Genetics, Autoantibodies and other Molecular Aspects of Idiopathic Inflammatory Myopathies and Models

Session Type: Abstract Submissions (ACR)

Background/Purpose: Inflammatory myopathies are a heterogeneous group of diseases. We investigated if the location and pattern of deposition of complement membrane attack complex (MAC) can be used in the differential diagnosis of inflammatory myopathies.

Methods: We reviewed histological sections of 227 cases of muscle biopsies in which MAC was requested for diagnosis and analysed 145 cases with clear clinical and pathological diagnosis; 88 inflammatory myopathies, 31 muscular dystrophies and 26 controls. We reviewed the immunohistichemical location of MAC, HLA Class I, utrophin, neo-myosin, together with the standard histological sections of the muscle biopsies.

Results: MAC deposition was demonstrated in 86.2% of dermatomyositis (DM), 86.5% of inclusion body myositis (IBM) and about 50% of patients with polymyositis (PM) and mixed connective tissue disease( MCTD). Most of the DM cases (55%) showed continuous solid and strong staining pattern in the capillary wall (pattern 1) with clear tendency of perifascicular deposition but with no sarcolemmal labelling. Samples from muscles with IBM, PM and MCD showed lighter granular segmental staining (pattern 2) in the capillaries, which is frequently associated with frequent granular staining in sarcolemma of muscle fibres across the fascicles. About 31% of DM biopsies showed a mixture of patterns 1 and 2.

There were infrequent granular and infrequent granular deposits in the capillaries in about 13% of muscular dystrophies and 11% in control cases.

Conclusion: Pattern 1 deposition of MAC in capillaries appears to be more frequent in DM and could contribute to the diagnosis, in addition to other criteria. This pattern of deposition may indicative of primary humoral mechanism involving capillaries in DM. Pattern 2 deposition of MAC in capillaries and sarcolemma of other inflammatory diseases, such as IBM and PM, could suggest complement system activation secondary to the inflammatory process and muscle necrosis.


Disclosure:

P. Gordon,
None;

N. Villagra,
None;

I. Bodi,
None;

A. King,
None;

S. Buk,
None;

T. Hortobagyi,
None;

S. Al-Sarraj,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/is-the-pattern-of-capillary-deposition-of-complement-membrane-attack-copmlex-useful-in-the-differential-diagnosis-of-inflammatory/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology